SCHEMBL30096938

SCHEMBL30096938

CP(C)(=O)c1ccc(NN)nc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.42
▸ GAA P10253 5/20 0.42
▸ MAPT P10636 4/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ NNMT P40261 1/20 0.33
▸ RAB9A P51151 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ FDPS P14324 2/20 0.31
▸ FDFT1 P37268 1/20 0.31
▸ HCAR3 P49019 1/20 0.31
▸ DEGS1 O15121 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ PTK2 Q05397 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23832350 1.00 KDM4E (0.42) KDM4EGAAMAPTMEN1LMNA
SCHEMBL21017085 0.78 VNN1 (0.36) KDM4EMAPTRAB9ADEGS1
SCHEMBL13536643 0.71 HDAC1 (0.42) KDM4ELMNARAB9AHPGD
SCHEMBL30096939 0.70 NNMT (0.37) KDM4EGAAMAPTMEN1LMNA
SCHEMBL23833635 0.70 NNMT (0.37) KDM4EGAAMAPTMEN1LMNA
SCHEMBL29849881 0.69 CYP2A6 (0.34) HPGD
SCHEMBL23832408 0.69 FDFT1 (0.41) FDFT1HPGD
SCHEMBL27037217 0.69 NAPRT (0.41) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL30096957 0.69 FDFT1 (0.41) FDFT1HPGD
SCHEMBL248181 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115605467-B PHD inhibitor compounds, compositions and uses thereof 阿克比治疗有限公司 2025-06-13 — — CN disclosed
CN-120004851-A PHD inhibitor compounds, compositions and uses thereof 阿克比治疗有限公司 2025-05-16 — — CN disclosed
EP-4121424-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND THEIR USE Akebia Therapeutics Inc. (US) 2023-01-25 — — EP disclosed
EP-4121426-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND USE Akebia Therapeutics Inc. (US) 2023-01-25 — — EP disclosed
Send feedback